Charles River Laboratorie (CRL) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts CRL Hot Sheet
Price: $225.86 -0.41%
Revenue Growth %: -5.1%
Financial Fact:
Selling, general and administrative: 85.65M
Today's EPS Names:
CRMT, FOMI, FLES, More
Revenue Growth %: -5.1%
Financial Fact:
Selling, general and administrative: 85.65M
Today's EPS Names:
CRMT, FOMI, FLES, More
Join SI Premium – FREE
Charles River Laboratorie (NYSE: CRL) reported Q1 EPS of $0.79, $0.03 worse than the analyst estimate of $0.82. Revenue for the quarter came in at $320.4 million versus the consensus estimate of $324 million.
Charles River Laboratorie sees FY2015 EPS of $3.55-$3.65, versus the consensus of $3.60.
For earnings history and earnings-related data on Charles River Laboratorie (CRL) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FactSet (FDS) Tops Q3 EPS by 8c ; Offers Guidance
- PPHC acquires London firm Tancredi for up to £25 million
- Goldman Regional Director in US Adjusts List of Top Names
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
